About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker RNTX

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Aug 14, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
Daniel Schneeberger4.50M5.3%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
ADAR1 Capital Management, LLC4.50M5.3%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Lynwood Opportunities Master Fund4.28M5.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Ben Shapiro4.28M5.0%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Lynwood Capital Management Inc.4.28M5.0%SCHEDULE 13G/A ↗
Aug 13, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Laurence W. Lytton4.24M4.9%SCHEDULE 13G/A ↗
Jul 14, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Travis W. Cocke5.66M6.6%SCHEDULE 13G/A ↗
Jul 14, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Capital, LP5.66M6.6%SCHEDULE 13G/A ↗
Jul 14, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Advisors GP, LLC1.50M1.8%SCHEDULE 13G/A ↗
Jul 14, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Value-Oriented Special Situations Fund, LP500,0000.6%SCHEDULE 13G/A ↗
Jul 14, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Value Master Fund, LP1.00M1.2%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios 2024 Co-Invest, LP562,6950.7%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios 2026 Co-Invest, LP1.00M1.3%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios LTI SPV II, LP1.49M1.9%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios LTI Co-Invest III, LP4.20M5.4%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios LTI Co-Invest III QP, LP4.30M5.5%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Fund I QP, LP941,8871.2%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Aaron G.L. Fletcher7.80M10.0%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Leslie W. Kreis7.80M10.0%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Cavu Management, LP7.80M10.0%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Cavu Advisors, LLC7.80M10.0%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Equity Partners III, LP1.75M2.2%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Equity Partners II, LP1.87M2.4%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Equity Cof, LP1.75M2.2%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Fund III, LP204,0920.3%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Advisors GP, LLC7.80M10.0%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Fund III NT, LP214,3460.3%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Fund III QP, LP1.33M1.7%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Clinical Opportunity Fund, LP2.31M3.0%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Equity Partners, LP1,2490.0%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Fund II NT, LP173,2170.2%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Fund II QP, LP1.30M1.7%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Fund II, LP398,7670.5%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Capital Management, LP7.80M10.0%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Bios Fund I, LP1.61M2.1%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
Lynwood Opportunities Master Fund4.75M6.1%SCHEDULE 13G ↗
May 8, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
Benjamin Shapiro4.75M6.1%SCHEDULE 13G ↗
May 8, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
Lynwood Capital Management Inc.4.75M6.1%SCHEDULE 13G ↗
May 7, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
Jacob Ma-Weaver5.20M6.7%SCHEDULE 13G ↗
May 7, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
Cable Car Capital, LP5.20M6.7%SCHEDULE 13G ↗
May 7, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
Funicular Funds, LP5.20M6.7%SCHEDULE 13G ↗
May 6, 2026SCHEDULE 13GRNTX
Rein Therapeutics, Inc.
Laurence W. Lytton4.50M5.8%SCHEDULE 13G ↗
Feb 13, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Travis W. Cocke4.47M17.0%SCHEDULE 13G/A ↗
Feb 13, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Capital, LP4.47M17.0%SCHEDULE 13G/A ↗
Feb 13, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Advisors GP, LLC1.43M5.4%SCHEDULE 13G/A ↗
Feb 13, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Value-Oriented Special Situations Fund, LP500,0001.9%SCHEDULE 13G/A ↗
Feb 13, 2026SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Value Master Fund, LP926,4413.5%SCHEDULE 13G/A ↗
Sep 26, 2025SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Travis W. Cocke2.67M11.3%SCHEDULE 13G/A ↗
Sep 26, 2025SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Capital, LP2.67M11.3%SCHEDULE 13G/A ↗
Sep 26, 2025SCHEDULE 13G/A (amended)RNTX
Rein Therapeutics, Inc.
Voss Advisors GP, LLC1.02M4.3%SCHEDULE 13G/A ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:26 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances